UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Development of an individualized procedure to induce reward-related impulsivity and evaluating its impact on drinking control

Addictive behaviors, 2022-10, Vol.133, p.107378-107378, Article 107378

2022

Link zum Volltext

Verfügbarkeit prüfen

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

The New England journal of medicine, 2014-03, Vol.370 (13), p.1189-1197

2014

Link zum Volltext

Verfügbarkeit prüfen

ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non–Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2017-09, Vol.12 (9), p.1357-1367

2017

Link zum Volltext

Verfügbarkeit prüfen

Effects of meal type on the oral bioavailability of the ALK inhibitor ceritinib in healthy adult subjects

Journal of clinical pharmacology, 2016-05, Vol.56 (5), p.559-566

2016

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic capability of low- versus high-field magnetic resonance imaging for lumbar degenerative disease

Spine (Philadelphia, Pa. 1976), 2015-03, Vol.40 (6), p.382-391

2015

Link zum Volltext

Verfügbarkeit prüfen

Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

Journal of thoracic oncology, 2020-03, Vol.15 (3), p.392-403

2020

Link zum Volltext

Verfügbarkeit prüfen

Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects

American journal of physiology: endocrinology and metabolism, 2009-11, Vol.297 (5), p.E1105-E1114

2009

Link zum Volltext

Verfügbarkeit prüfen

Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems

The Journal of pharmacology and experimental therapeutics, 2006-02, Vol.316 (2), p.762

2006

Link zum Volltext

Verfügbarkeit prüfen

Application of time-dependent modeling for the exposure–efficacy analysis of ceritinib in untreated ALK-rearranged advanced NSCLC patients

Cancer chemotherapy and pharmacology, 2019-09, Vol.84 (3), p.501-511

2019

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Ceritinib in Adult Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase

Journal of clinical pharmacology, 2017-05, Vol.57 (5), p.652-662

2017

Link zum Volltext

Verfügbarkeit prüfen

Predation by Red Foxes (Vulpes vulpes) at an Outdoor Piggery

Animals (Basel), 2016-10, Vol.6 (10), p.60-60

2016

Link zum Volltext

Verfügbarkeit prüfen

Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes

PloS one, 2012-11, Vol.7 (11), p.e49345-e49345

2012

Link zum Volltext

Verfügbarkeit prüfen

Changes in dural sac caliber with standing MRI improve correlation with symptoms of lumbar spinal stenosis

European spine journal, 2017-10, Vol.26 (10), p.2666-2675

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non–small cell lung cancer previously treated with crizotinib: Results from ASCEND-6

Lung cancer (Amsterdam, Netherlands), 2020-12, Vol.150, p.240-246

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug–drug interaction study in patients with ALK + advanced tumors

Cancer chemotherapy and pharmacology, 2021-04, Vol.87 (4), p.475-486

2021

Link zum Volltext

Verfügbarkeit prüfen

Liquid chromatography tandem mass spectrometry method for the quantitative analysis of ceritinib in human plasma and its application to pharmacokinetic studies

Analytical and bioanalytical chemistry, 2014-11, Vol.406 (28), p.7389-7396

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism

Drug metabolism and disposition, 2006-07, Vol.34 (7), p.1175

2006

Link zum Volltext

Verfügbarkeit prüfen

Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys

The Journal of pharmacology and experimental therapeutics, 2009-04, Vol.329 (1), p.102

2009

Link zum Volltext

Verfügbarkeit prüfen

Improvement of learning domains of nursing students with the use of authentic assessment pedagogy in clinical practice

Nurse education in practice, 2016-09, Vol.20, p.125-130

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of drug–drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2017-06, Vol.79 (6), p.1119-1128

2017

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis

Journal of clinical pharmacology, 2012-08, Vol.52 (8), p.1150-1161

2012

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Changes in dural sac caliber with standing MRI improve correlation with symptoms of lumbar spinal stenosis

European spine journal, 2017-10, Vol.26 (10), p.2676-2677

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a simplified therapeutic intervention scoring system (TISS-28) and the modified early warning score (MEWS) in predicting physiological deterioration during inter-facility transport

Resuscitation, 2008-01, Vol.76 (1), p.47-51

2008

Link zum Volltext

Verfügbarkeit prüfen

Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay

The Journal of pharmacology and experimental therapeutics, 2004-03, Vol.308 (3), p.1040

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(160)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Development of an individualized procedure to induce reward-related impulsivity and evaluating its impact on drinking control

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non–Small Cell Lung Cancer (NSCLC)

Effects of meal type on the oral bioavailability of the ALK inhibitor ceritinib in healthy adult subjects

Diagnostic capability of low- versus high-field magnetic resonance imaging for lumbar degenerative disease

Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects

Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)–Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study

Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems

Application of time-dependent modeling for the exposure–efficacy analysis of ceritinib in untreated ALK-rearranged advanced NSCLC patients

Population Pharmacokinetics of Ceritinib in Adult Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase

Predation by Red Foxes (Vulpes vulpes) at an Outdoor Piggery

Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes

Changes in dural sac caliber with standing MRI improve correlation with symptoms of lumbar spinal stenosis

Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non–small cell lung cancer previously treated with crizotinib: Results from ASCEND-6

Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug–drug interaction study in patients with ALK + advanced tumors

Liquid chromatography tandem mass spectrometry method for the quantitative analysis of ceritinib in human plasma and its application to pharmacokinetic studies

Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism

Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys

Improvement of learning domains of nursing students with the use of authentic assessment pedagogy in clinical practice

Assessment of drug–drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer

Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis

Erratum to: Changes in dural sac caliber with standing MRI improve correlation with symptoms of lumbar spinal stenosis

Evaluation of a simplified therapeutic intervention scoring system (TISS-28) and the modified early warning score (MEWS) in predicting physiological deterioration during inter-facility transport

Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay

Suchergebnisse filtern